Baricitinib vs Irbesartan

Baricitinib vs Irbesartan: Overview

This comparison examines the pharmacological differences between Baricitinib and Irbesartan.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Irbesartan — 11-15 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Irbesartan — C25H28N6O.

Molecular Weight: Baricitinib — 371.4170 g/mol; Irbesartan — 428.5320 g/mol.

Type: Baricitinib — Small molecule; Irbesartan — Small molecule.